000			02066 a2200637 4500
005			20250517204233.0
264		0	_c20190625
008			201906s 0 0 eng d
022			_a1879-1913
024	7		_a10.1016/j.amjcard.2018.01.038 _2doi
040			_aNLM _beng _cNLM
100	1		_aJaakkola, Samuli
245	0	0	_aUsefulness of the CHA _h[electronic resource]
260			_bThe American journal of cardiology _c05 2018
300			_a1182-1186 p. _bdigital
500			_aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aAtrial Fibrillation _xcomplications
650	0	4	_aBrain Ischemia _xepidemiology
650	0	4	_aCross-Sectional Studies
650	0	4	_aDabigatran _xadverse effects
650	0	4	_aDecision Support Techniques
650	0	4	_aDiabetes Mellitus
650	0	4	_aFemale
650	0	4	_aFinland _xepidemiology
650	0	4	_aHeart Failure
650	0	4	_aHemorrhage
650	0	4	_aHumans
650	0	4	_aHypertension
650	0	4	_aInternational Normalized Ratio
650	0	4	_aIntracranial Hemorrhages _xchemically induced
650	0	4	_aIschemic Attack, Transient
650	0	4	_aKidney Function Tests
650	0	4	_aLiver Function Tests
650	0	4	_aMale
650	0	4	_aPatient Selection
650	0	4	_aRisk Assessment
650	0	4	_aSex Factors
650	0	4	_aStroke _xepidemiology
650	0	4	_aThromboembolism
650	0	4	_aVascular Diseases
650	0	4	_aWarfarin _xadverse effects
700	1		_aKiviniemi, Tuomas O
700	1		_aNuotio, Ilpo
700	1		_aHartikainen, Juha
700	1		_aMustonen, Pirjo
700	1		_aPalomäki, Antti
700	1		_aJaakkola, Jussi
700	1		_aYlitalo, Antti
700	1		_aHartikainen, Päivi
700	1		_aAiraksinen, K E Juhani
773	0		_tThe American journal of cardiology _gvol. 121 _gno. 10 _gp. 1182-1186
856	4	0	_uhttps://doi.org/10.1016/j.amjcard.2018.01.038 _zAvailable from publisher's website
999			_c28166429 _d28166429